ASX Announcements

Investor presentation, 23 March 2021
S&P DJI Announces March 2021 Quarterly Rebalance
Neuren successfully completes manufacturing for Phase 2
Neuren corporate presentation, 24 February 2021
Neuren approaching transforming milestones in 2021
Preliminary Final Report and 2020 full year accounts
Change of Director's Interest Notice
Notification of investor briefing webinar
Neuren adds Prader-Willi syndrome to NNZ-2591 pipeline
Successful Phase 1 trial for Neuren's NNZ-2591